Newsletter 5

Pharma Stock Returns | Behavioural therapy in India | Top 5 Healthtech / Medtech startups | Brain Computer Interface (AI | US/China) | Corporate Updates | Upcoming Podcast

Author

Agenda Health AH
July 02, 2025

Indian MedTech|AI Innovation: Muse Diagnostics

Muse Diagnostics, founded in 2014 in Bangalore, India, develops advanced, affordable medical devices with a focus on open-source solutions. Their flagship product, the eTAAL Digital Stethoscope, offers high-quality sound for telemedicine and remote patient monitoring. A digital App “eMURMUR” works with “eTAAL” as an Auscultation Software.

MUSE Diagnostics is a Bangalore based ​Medical Device company founded by a Veterinarian, a Sound Engineer & a Geneticist. (LinkedIn)

Welcome to all the supporters of Agenda+Health, here’s is what to expect:

  • Pharma STOCK Returns (June'24-25)

  • Survey: Behavioural therapy Awareness

  • Top 5 Healthtech | Medtech startups

  • AI | Medtech : Brain Computer Interface

  • Corporate Updates: Indian Healthcare

  • Upcoming Podcast announcement

Read time: 5 minutes

1/ Pharma STOCK Returns (June’24-25)

  • Wockhardt led with an impressive 203.89% stock return from June 2024 to June 2025, outpacing all peers.

  • Blue Jet and Neuland Lab followed with strong returns of 124.82% and 88.76%, respectively.

  • Several companies, including Cipla, Glenmark, and Divi's Lab, recorded returns between 34% and 49%.

  • Orchid Pharma experienced the largest decline, with a 35.35% drop in stock value.

  • The majority of pharmaceutical stocks showed positive returns, with only a few, like Emcure and Sai Life, recording negative growth

Performance of 30+ Pharma Stocks for the duration - June’24 - June’25

2/ Behavioural therapy Awareness in Indian Families

We have conducted an awareness survey to understand the challenges families face in accessing behavioural therapy for their children. A critical observation is the overwhelming lack of awareness (58%).

Further, concerns have been raised with regards to the therapy sessions in terms of value for money, quality of care and the way the sessions are conducted leaving the parents less than desired experience.

3/ Uprising Healthtech | Medtech startups in INDIA

MicroHeal is pioneering hybrid therapy by combining pharmaceutical treatments with non-pharmaceutical digital interventions, designed to manage Functional Gastrointestinal Disorders (FGID) (Gut related disorders like IBS)

Apex Cura is a SaaS-based healthcare AI platform designed to optimize hospital operations and improve patient outcomes with their flagship product, Apex AI Agent, integrating with hospital management systems.

AI Steth is developing an AI-powered digital stethoscope that enhances diagnostic accuracy by analyzing heart and lung sounds.

Taurean Surgical, Their flagship product, a robot-assisted 3D surgical microscope integrated with AI, enhances surgical precision and visualization for neurosurgery, ENT, and head and neck procedures.

Aignosis is revolutionizing early autism screening with an AI-driven, non-invasive tool that uses a standard webcam for assessments.

4/ AI | Medtech News

In a ground-breaking achievement, a team led by Professor Duan Feng at Nankai University successfully conducted the world’s first human trial of a brain-computer interface (BCI) implanted via blood vessels, enabling a 67-year-old man paralyzed on one side due to a stroke to regain limb movement.

The minimally invasive procedure involved inserting a stent electrode into brain blood vessels through a neck vein, guided by high-precision imaging, avoiding the need for invasive skull surgery as used by approaches like Neuralink.

Neuralink has laid out a roadmap starting with "Blindsight," a pioneering project aiming to restore vision ,even for those born blind, by streaming video directly to the brain's visual cortex, with the first human trial planned for 2026.

Their plan involves an exponential increase in the implant's electrode count over the next four years, paving the way for finer motor control, speech decoding, and addressing a wider range of neurological conditions.

For a detailed technical and clinical analysis, please see the attached report.

Neuralink_ Status, Progress and Roadmap.pdf100.67 KB • PDF File

5/ Corporate Updates: Indian Healthcare (by Anshul Agrawal)

  • Dr Lal Pathlabs strengthens its genomics capabilities with Illumina's NovaSeq X Series (Source)

  • Indira IVF acquires Ahmedabad-based Banker IVF to expand fertility care services (Source)

  • Apollo HealthCo to be ₹30,000 crore company in 5-6 yrs, says Shobana Kamineni (Source)

  • Suraksha Diagnostics to invest Rs 200 cr to set up over 20 centres across east India (Source)

  • Manipal, Fortis in talks to raise Rs 5,000 cr for Sahyadri Hospitals bid (Source)

  • ISN Exclusive: ex-Ola executive Varun Dubey starts up a hospital chain, in talks to raise seed funding (Source)

6/ Agenda Health Upcoming Podcast

We have an upcoming podcast with Dr. Sonam Kothari is a Paediatric Neurologist (MBBS, MD-PhD) (National Institute of Mental Health and Neuro Sciences (NIMHANS), India)

The prevalence of Autism's increased from 1-in-110 to 1-in-36 kids since 2006. In this Podcast, we tried to go deeper into:

  • The Science of Autism

  • The Societal level issues

  • Doctors to Parents to Schools Point of View.